Dian Ying Jing - 25 Aug 2025 Form 3 Insider Report for Curanex Pharmaceuticals Inc

Role
Secretary, 10%+ Owner
Signature
/s/ Dian Ying Jing
Issuer symbol
CURX on Nasdaq
Transactions as of
25 Aug 2025
Net transactions value
$0
Form type
3
Filing time
02 Sep 2025, 20:30:09 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Jing Dian Ying Secretary, 10%+ Owner C/O CURANEX PHARMACEUTICALS INC, 2 JERICHO PLAZA SUITE 101 B, JERICHO /s/ Dian Ying Jing 02 Sep 2025 0002083648

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CURX Common Stock 3,248,400 25 Aug 2025 Direct
holding CURX Common Stock 912,600 25 Aug 2025 see footnote F1
holding CURX Common Stock 7,076,160 25 Aug 2025 see footnote F2
holding CURX Series A Preferred Stock 200,000 25 Aug 2025 Direct
holding CURX Series A Preferred Stock 490,000 25 Aug 2025 see footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of common stock are beneficially owned by the Reporting Person through Doublewin Developer LLC, an entity in which the Reporting Person has sole voting and investment power. By virtue of this relationship, the Reporting Person may be deemed to have sole beneficial ownership of the securities held of record by Doublewin Developer LLC.
F2 These shares of common stock are beneficially owned by the Reporting Person through her husband, Jun Liu, the Company's Chief Executive Officer and President, who holds these shares directly. By virtue of this relationship, the Reporting Person may be deemed to share beneficial ownership of the securities held of record by Jun Liu.
F3 These shares of Series A Preferred Stock are beneficially owned by the Reporting Person through her husband, Jun Liu, the Company's Chief Executive Officer and President, who holds these shares directly. By virtue of this relationship, the Reporting Person may be deemed to share beneficial ownership of the securities held of record by Jun Liu.